- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
DoorDash lets in $3.37bn through IPO
SoftBank Vision Fund is the largest investor in the food delivery service, which has priced an upsized initial public offering roughly doubling its valuation six months ago.
Dec 9, 2020Getsafe gathers $30m for series B
Swiss Re subsidiary IptiQ led the digital insurance app developer’s series B round, which increased its overall funding to $53m.
Dec 9, 2020Silverback swells IPO to near $278m
The underwriters have taken up the over-allotment option in BMS and Celgene-backed oncology drug developer Silverback's initial public offering.
Dec 9, 2020Corporates help Dragos drag in $110m
National Grid Partners and Koch Disruptive Technologies co-led the industrial cybersecurity product developer's series C round, taking its total funding to $158m.
Dec 9, 2020RayzeBio lays out $105m in series B
Alexandria Venture Investments was among the participants in the cancer radiotherapy startup's second round in under two months.
Dec 9, 2020SciNeuro signs off on $100m series A
Lilly Asia Ventures co-led the first round for the CNS disease drug developer, which is headed by one of its former venture partners.
Dec 9, 2020Deepcell caps $20m series A
Stanford University supplied capital to help its AI cell analysis spinout Deepcell close its second funding round.
Dec 9, 2020Bristol endorses Science Creates
Science Creates will combine a $20m fund with wet-lab incubation to foster the west of England deep tech ecosystem in partnership with University of Bristol.
Dec 9, 2020Gohenry waves through $40m
Citi Ventures participated in the first non-crowdfunded equity round to be disclosed by the kids' finance management app developer.
Dec 9, 2020HeiQ harvests $80.1m from UK listing
ETH Zurich-founded HeiQ chose the London Stock Exchange for its listing having posted a $10.9m operating profit for the first half of the year.
Dec 9, 2020Ro reels in Workpath
Heritage Group has exited Workpath, a developer of in-home care management software, through an acquisition by Ro.
Dec 9, 2020Vigil emerges with $50m
Amgen is a shareholder of Vigil Neuroscience, which is developing microglia-based treatments for neurodegenerative diseases.
Dec 9, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
